A BillionToOne co-founder, Oguzhan believes that diagnostics can be made much more powerful, accurate, and affordable if they are engineered to be quantitative. Oguzhan helped develop our proprietary molecular counting platform. He has led the Company since its inception and raised more than $200M in funding including from venture capital funds and investors who previously invested in tech companies such as SpaceX, Box, Spotify, Palantir, Braintree, and biotech companies such as Counsyl, WebMD, and Omada Health. Oguzhan received his PhD from Stanford University, where his work was published on the Cover of Cell Systems. He graduated summa cum laude and Phi Beta Kappa from Princeton University with a bachelor’s in molecular biology and minors in physics, computer science, and applied mathematics.

Read Oguzhan's Founder's Letter